Tectonic Therapeutic (TECX) Operating Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Operating Expenses data on file, last reported at $27.3 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $27.3 million, up 49.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.0 million (up 46.87% YoY), and the FY2025 annual result was $84.0 million, up 44.85% from the prior year.
• Operating Expenses climbed to $27.3 million in Q1 2026 per TECX's latest filing, from $21.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $29.4 million in Q1 2022 and troughed at $9.4 million in Q4 2023.
• A 5-year average of $19.4 million and a median of $21.5 million in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses sank 62.89% in 2023, then jumped 95.53% in 2025.
• A 5-year view of Operating Expenses shows it stood at $25.3 million in 2022, then slumped by 62.89% to $9.4 million in 2023, then soared by 49.25% to $14.0 million in 2024, then jumped by 53.78% to $21.5 million in 2025, then grew by 26.89% to $27.3 million in 2026.
• Business Quant data shows TECX's Operating Expenses at $27.3 million in Q1 2026, $21.5 million in Q4 2025, and $21.9 million in Q3 2025.